Overall Survival with Ribociclib plus Fulvestrant in Advanced Breast Cancer

Original Article

D.J. Slamon, P. Neven, S. Chia, P.A. Fasching, M.D. Laurentiis, S.-A. Im, K. Petrakova, G.V. Bianchi, F.J. Esteva, M. Martín, A. Nusch, G.S. Sonke, L.D.l. Cruz-Merino, J.T. Beck, X. Pivot, M. Sondhi, Y. Wang, A. Chakravartty, K. Rodriguez-Lorenc, T. Taran, and G. Jerusalem

N Engl J Med 2020;382:514-524

Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
Course opens: 
02/05/2020
Course expires: 
02/06/2022

Available Credit

  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Course closed

This course closed on Sunday, February 6, 2022 - 11:59pm.